I have a couple of quick comments. At the moment nobody has that test, so this would be novel. Let me perhaps amplify that by saying that we already have two additional hurdles compared to any other market that regulates GM technologies. We have the plants with a novel trait hurdle, which is broader than the GE hurdle, and we have the Seeds Act efficacy test, which no other jurisdiction in the world has. So that would be the third additional requirement for researchers trying to commercialize a product in this country.
On October 5th, 2010. See this statement in context.